4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0000899243-17-029615
Director sold 3,059 shares at $20.29 ($62,070)
From the SEC's structured data for this filing
Trades in this filing
Woiwode Thomas · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2017-12-22 | Sale : show line 1 in the form | −3,059 | $20.29 | $62,070 | 4,959 | D |
| Open-market sales · 3,059 sh · avg $20.29 · $62,070 | ||||||
Loading xslF345X03/doc4.xml…